Correlation Between Beam Therapeutics and Adaptive Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Beam Therapeutics and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Adaptive Biotechnologies.
Diversification Opportunities for Beam Therapeutics and Adaptive Biotechnologies
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Beam and Adaptive is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Adaptive Biotechnologies go up and down completely randomly.
Pair Corralation between Beam Therapeutics and Adaptive Biotechnologies
Given the investment horizon of 90 days Beam Therapeutics is expected to generate 1.14 times less return on investment than Adaptive Biotechnologies. But when comparing it to its historical volatility, Beam Therapeutics is 1.14 times less risky than Adaptive Biotechnologies. It trades about 0.07 of its potential returns per unit of risk. Adaptive Biotechnologies Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 512.00 in Adaptive Biotechnologies Corp on August 30, 2024 and sell it today you would earn a total of 61.00 from holding Adaptive Biotechnologies Corp or generate 11.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Beam Therapeutics vs. Adaptive Biotechnologies Corp
Performance |
| Timeline |
| Beam Therapeutics |
| Adaptive Biotechnologies |
Beam Therapeutics and Adaptive Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beam Therapeutics and Adaptive Biotechnologies
The main advantage of trading using opposite Beam Therapeutics and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |